These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 8908316)
21. Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Bosscha K; Reijnders K; Hulstaert PF; Algra A; van der Werken C Br J Surg; 1997 Nov; 84(11):1532-4. PubMed ID: 9393271 [TBL] [Abstract][Full Text] [Related]
22. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Rafat N; Hanusch C; Brinkkoetter PT; Schulte J; Brade J; Zijlstra JG; van der Woude FJ; van Ackern K; Yard BA; Beck GCh Crit Care Med; 2007 Jul; 35(7):1677-84. PubMed ID: 17522579 [TBL] [Abstract][Full Text] [Related]
23. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock? Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857 [TBL] [Abstract][Full Text] [Related]
24. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240 [TBL] [Abstract][Full Text] [Related]
25. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Nguyen HB; Corbett SW; Steele R; Banta J; Clark RT; Hayes SR; Edwards J; Cho TW; Wittlake WA Crit Care Med; 2007 Apr; 35(4):1105-12. PubMed ID: 17334251 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. Simpson AJ; Smith MD; Weverling GJ; Suputtamongkol Y; Angus BJ; Chaowagul W; White NJ; van Deventer SJ; Prins JM J Infect Dis; 2000 Feb; 181(2):621-5. PubMed ID: 10669346 [TBL] [Abstract][Full Text] [Related]
27. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Kaneyama K; Segami N; Sun W; Sato J; Fujimura K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832 [TBL] [Abstract][Full Text] [Related]
28. Relationship between adrenal function and prognosis in patients with severe sepsis. Yang Y; Liu L; Zhao B; Li MQ; Wu B; Yan Z; Gu Q; Sun H; Qiu HB Chin Med J (Engl); 2007 Sep; 120(18):1578-82. PubMed ID: 17908474 [TBL] [Abstract][Full Text] [Related]
29. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease. Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105 [TBL] [Abstract][Full Text] [Related]
30. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Post F; Weilemann LS; Messow CM; Sinning C; Münzel T Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903 [TBL] [Abstract][Full Text] [Related]
31. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Granja C; Dias C; Costa-Pereira A; Sarmento A Crit Care; 2004 Apr; 8(2):R91-8. PubMed ID: 15025783 [TBL] [Abstract][Full Text] [Related]
32. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of cytokines in SIRS general medical patients. Rodríguez-Gaspar M; Santolaria F; Jarque-López A; González-Reimers E; Milena A; de la Vega MJ; Rodríguez-Rodríguez E; Gómez-Sirvent JL Cytokine; 2001 Aug; 15(4):232-6. PubMed ID: 11563884 [TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha and interleukin 6 in infants with sepsis. Makhija P; Yadav S; Thakur A Indian Pediatr; 2005 Oct; 42(10):1024-8. PubMed ID: 16269840 [TBL] [Abstract][Full Text] [Related]
35. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. Andrews B; Shariat SF; Kim JH; Wheeler TM; Slawin KM; Lerner SP J Urol; 2002 Mar; 167(3):1475-81. PubMed ID: 11832773 [TBL] [Abstract][Full Text] [Related]
36. Practice and perception--a nationwide survey of therapy habits in sepsis. Brunkhorst FM; Engel C; Ragaller M; Welte T; Rossaint R; Gerlach H; Mayer K; John S; Stuber F; Weiler N; Oppert M; Moerer O; Bogatsch H; Reinhart K; Loeffler M; Hartog C; Crit Care Med; 2008 Oct; 36(10):2719-25. PubMed ID: 18766100 [TBL] [Abstract][Full Text] [Related]
37. Immunological surrogate parameters in a prognostic model for multi-organ failure and death. Holzheimer RG; Capel P; Cavaillon JM; Cainzos M; Frileux P; Haupt W; Marie C; Müller E; Ohmann C; Schöffel U; Lopez-Boado MA; Sganga G; Stefani A; Kronberger L Eur J Med Res; 2000 Jul; 5(7):283-94. PubMed ID: 10903188 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 and soluble interleukin-6 receptor in cord blood in the diagnosis of early onset sepsis in neonates. Lehrnbecher T; Schrod L; Kraus D; Roos T; Martius J; von Stockhausen HB Acta Paediatr; 1995 Jul; 84(7):806-8. PubMed ID: 7549302 [No Abstract] [Full Text] [Related]
40. Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Weigand MA; Volkmann M; Schmidt H; Martin E; Böhrer H; Bardenheuer HJ Anesthesiology; 2000 Mar; 92(3):905-7. PubMed ID: 10719986 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]